Sec. 408. Medicare coverage for consultations
331 words·~2 min read·
/bill/117/hr/6000/ih/section-408·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 1861 of the Social Security Act ( 42 U.S.C. 1395x ) is amended— in subsection (s)(2)— by striking and at the end of subparagraph (GG); by striking the period at the end of subparagraph
(HH)and inserting ; and ; and by adding at the end the following new subparagraph: pharmacogenetic consultations provided by a qualified clinical pharmacist, genetic counselor, or pathologist (as such terms are defined in subsection (lll)). ; and by adding at the end the following new subsection: In this section: The term pharmacogenetic consultation means, with respect to a genetic or genomic test furnished to an individual, a consultation with respect to such test requested by the physician treating such individual to provide such physician with advice and recommendations regarding the dosage, safety, and efficacy of particular drugs, biologicals, and other treatments based on the individual's pharmacogenetic result. The term genetic counselor means an individual who— is licensed as a genetic counselor by the State in which the individual furnishes genetic counseling services; or in the case of an individual practicing in a State that does not license genetic counselors, meets such other criteria as the Secretary establishes. The term qualified clinical pharmacist means an individual— with a doctoral degree in pharmacy; who is licensed as a pharmacist in the State in which such individual furnishes consultations; has appropriate pharmacy specialty certifications or appropriate training, as determined by the Secretary; and meets other qualifications as specified by the Secretary. . Section 1832(a)(2) of the Social Security Act ( 42 U.S.C. 1395k(a)(2) ) is amended— by striking and at the end of subparagraph (I); by striking the period at the end of subparagraph
(J)and inserting ; and ; and by adding at the end the following new subparagraph: pharmacogenetic consultations (as defined in subsection (lll)). . The amendments made by subsections
(a)and
(b)shall apply to consultations furnished during a cost reporting period beginning on or after the date of the enactment of such subsections.
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources